XPeng (NYSE:XPEV – Get Free Report) will release its earnings data before the market opens on Tuesday, November 19th. XPeng has set its Q3 2024 guidance at EPS.Parties that are interested in registering for the company’s conference call can do so using this link.
XPeng (NYSE:XPEV – Get Free Report) last announced its quarterly earnings data on Tuesday, August 20th. The company reported ($0.19) earnings per share (EPS) for the quarter. XPeng had a negative net margin of 21.64% and a negative return on equity of 23.38%. The company had revenue of $1.12 billion for the quarter. On average, analysts expect XPeng to post $-1 EPS for the current fiscal year and $0 EPS for the next fiscal year.
XPeng Trading Up 0.9 %
NYSE XPEV opened at $12.74 on Monday. XPeng has a 12 month low of $6.55 and a 12 month high of $18.74. The company has a current ratio of 1.50, a quick ratio of 1.31 and a debt-to-equity ratio of 0.18. The stock’s fifty day moving average price is $11.44 and its 200-day moving average price is $9.17. The stock has a market cap of $12.00 billion, a P/E ratio of -10.44 and a beta of 2.80.
Wall Street Analyst Weigh In
Read Our Latest Analysis on XPEV
XPeng Company Profile
XPeng Inc designs, develops, manufactures, and markets smart electric vehicles (EVs) in the People's Republic of China. It offers SUVs under the G3, G3i, and G9 names; four-door sports sedans under the P7 and P7i names; and family sedans under the P5 name. The company also provides sales contracts, super charging, maintenance, technical support, auto financing, insurance, technology support, ride-hailing, automotive loan referral, and other services, as well as vehicle leasing and insurance agency services.
Recommended Stories
- Five stocks we like better than XPeng
- The 3 Best Blue-Chip Stocks to Buy Now
- Warren Buffett, Cathie Wood Own Nu Holdings, Should You?
- Financial Services Stocks Investing
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- What Does a Gap Up Mean in Stocks? How to Play the Gap
- ORIC: Working with Two Pharma Giants, Analysts See +100% Upside
Receive News & Ratings for XPeng Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for XPeng and related companies with MarketBeat.com's FREE daily email newsletter.